N. Anthony Coles serves as Executive at NPS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, N. Anthony Coles has executed 174 insider transactions totaling $79.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 1, 2024 involved selling 15,638 shares valued at $0.
N. Anthony Coles currently holds 10,290 shares of NPS PHARMACEUTICALS INC (NPSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, N. Anthony Coles has been a net seller of NPSP stock. They have purchased $0 and sold $79.1M worth of shares.
N. Anthony Coles's most recent insider trade was on Aug 1, 2024, when they sold 15,638 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 1, 2024 | CERE | $1.0M | Sale | 25,000 | $41.18 | Planned |
| Jul 1, 2024 | CERE | $87.5K | Option Exercise | 25,000 | $3.50 | Planned |
| Jun 5, 2024 | CERE | $0 | Award | 10,290 | $N/A | Discretionary |
| Jun 3, 2024 | CERE | $175.0K | Option Exercise | 50,000 | $3.50 | Planned |
| Jun 3, 2024 | CERE | $2.0M | Sale | 50,000 | $40.61 | Planned |
| May 10, 2024 | CERE | $175.0K | Option Exercise | 50,000 | $3.50 | Planned |
| May 10, 2024 | CERE | $2.1M | Sale | 50,000 | $42.10 | Planned |
| Apr 1, 2024 | CERE | $175.0K | Option Exercise | 50,000 | $3.50 | Planned |
| Apr 1, 2024 | CERE | $2.1M | Sale | 50,000 | $42.33 | Planned |
| Mar 4, 2024 | CERE | $2.1M | Sale | 50,000 | $41.01 | Planned |
| Mar 4, 2024 | CERE | $175.0K | Option Exercise | 50,000 | $3.50 | Planned |
| Feb 29, 2024 | CERE | $2.1M | Sale | 50,000 | $41.16 | Planned |
| Feb 29, 2024 | CERE | $175.0K | Option Exercise | 50,000 | $3.50 | Planned |
| Feb 7, 2024 | CERE | $104.1K | Sale | 2,506 | $41.54 | Discretionary |
| Feb 6, 2024 | CERE | $0 | Option Exercise | 15,440 | $N/A | Discretionary |
| Jan 2, 2024 | REGN | $0 | Award | 135 | $N/A | Discretionary |
| Jan 2, 2024 | CERE | $2.1M | Sale | 50,000 | $42.24 | Planned |
| Jan 2, 2024 | CERE | $175.0K | Option Exercise | 50,000 | $3.50 | Planned |
| Nov 14, 2023 | CERE | $573.6K | Sale | 22,824 | $25.13 | Discretionary |
| Nov 14, 2023 | CERE | $79.9K | Option Exercise | 22,824 | $3.50 | Discretionary |
| Nov 8, 2023 | CERE | $350 | Option Exercise | 100 | $3.50 | Discretionary |
| Nov 8, 2023 | CERE | $2.5K | Sale | 100 | $25.16 | Discretionary |
| Nov 7, 2023 | CERE | $94.8K | Option Exercise | 27,076 | $3.50 | Discretionary |
| Nov 7, 2023 | CERE | $677.4K | Sale | 27,076 | $25.02 | Discretionary |
| Nov 3, 2023 | CERE | $214.9K | Option Exercise | 61,401 | $3.50 | Discretionary |
| Nov 3, 2023 | CERE | $1.6M | Sale | 61,401 | $25.43 | Discretionary |
| Nov 2, 2023 | CERE | $972.3K | Sale | 38,599 | $25.19 | Discretionary |
| Nov 2, 2023 | CERE | $135.1K | Option Exercise | 38,599 | $3.50 | Discretionary |